Corneal complications and NSAIDs

      The Guest Editorial by Dr. Allan Flach in the July 2000 issue of Ophthalmology is highly critical of the manner in which ASCRS, ASOA, Dr. Kenneth Rosenthal, and several tabloids handled the issue of corneal complications attributed to the use of topical nonsteroidal antiinflammatory drugs (NSAIDs). As a full-time academician and associate journal editor, I agree with his assertion that the peer-review process is the ideal (though still imperfect) arbiter of scientific validity. However, as a clinician and guardian of my patient’s best interests, I believe that it is foolhardy, impractical, and unethical to always await peer-reviewed reports before intervening in matters that affect patient safety.
      To read this article in full you will need to make a payment


      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Linked Article